Advertisement
Screener

Neogen Corporation (NEOG) Operating Income

Neogen Corporation Operating Income

Neogen Corporation (NEOG) reported Operating Income of -$21.60 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-07-30

  • Neogen Corporation operating income (loss) for the quarter ending 2026-05-31 was $3.10M.
  • Neogen Corporation operating income (loss) for the quarter ending 2026-02-28 was -$3.30M, a 161.11% decline year-over-year.
  • Neogen Corporation operating income (loss) for the quarter ending 2025-11-30 was -$5.38M.
  • Neogen Corporation operating income (loss) for the quarter ending 2025-08-31 was -$16.09M, a 812.94% decline year-over-year.
  • Neogen Corporation operating income (loss) for fiscal 2026 was -$21.60M.
  • Neogen Corporation operating income (loss) for fiscal 2025 was -$1.06B, a 1910.58% decline from fiscal 2024.
  • Neogen Corporation operating income (loss) for fiscal 2024 was $58.60M, a 56.20% increase from fiscal 2023.
  • Neogen Corporation operating income (loss) for fiscal 2023 was $37.52M, a 36.00% decline from fiscal 2022.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-05-31$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
-$200.00K
derived: sum of 2 quarters · filed 2026-07-30
-$5.58M
derived: sum of 3 quarters · filed 2026-07-30
-$21.60M
10-K · filed 2026-07-30
2026-02-28-$3.30M
10-Q · filed 2026-04-09
-$8.68M
derived: sum of 2 quarters · filed 2026-04-09
-$24.70M
10-Q · filed 2026-04-09
-$635.97M
derived: sum of 4 quarters · filed 2026-07-30
2025-11-30-$5.38M
10-Q · filed 2026-01-08
-$21.47M
10-Q · filed 2026-01-08
-$632.67M
derived: sum of 3 quarters · filed 2026-07-30
-$627.27M
derived: sum of 4 quarters · filed 2026-07-30
2025-08-31-$16.09M
10-Q · filed 2025-10-09
-$627.29M
derived: sum of 2 quarters · filed 2026-07-30
-$621.89M
derived: sum of 3 quarters · filed 2026-07-30
-$1.08B
derived: sum of 4 quarters · filed 2026-07-30
2025-05-31-$611.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
-$605.80M
derived: sum of 2 quarters · filed 2026-07-30
-$1.06B
derived: sum of 3 quarters · filed 2026-07-30
-$1.06B
10-K · filed 2026-07-30
-$1.06B
10-K · filed 2025-07-30
2025-02-28$5.40M
10-Q · filed 2026-04-09
$5.42M
10-Q · filed 2025-04-09
-$452.08M
derived: sum of 2 quarters · filed 2026-04-09
-$449.80M
10-Q · filed 2026-04-09
-$449.81M
10-Q · filed 2025-04-09
-$436.85M
derived: sum of 4 quarters · filed 2026-07-30
2024-11-30-$457.48M
10-Q · filed 2026-01-08
-$455.23M
10-Q · filed 2026-01-08
-$442.25M
derived: sum of 3 quarters · filed 2026-07-30
-$430.23M
derived: sum of 4 quarters · filed 2026-07-30
2024-08-31$2.26M
10-Q · filed 2025-10-09
$15.23M
derived: sum of 2 quarters · filed 2026-07-30
$27.26M
derived: sum of 3 quarters · filed 2026-07-30
$41.72M
derived: sum of 4 quarters · filed 2026-07-30
2024-05-31$12.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
$25.00M
derived: sum of 2 quarters · filed 2026-07-30
$39.47M
derived: sum of 3 quarters · filed 2026-07-30
$58.60M
10-K · filed 2026-07-30
$58.66M
10-K · filed 2024-07-30
2024-02-29$12.02M
10-Q · filed 2025-04-09
$26.49M
derived: sum of 2 quarters · filed 2025-04-09
$45.62M
10-Q · filed 2025-04-09
$69.05M
derived: sum of 4 quarters · filed 2025-07-30
2023-11-30$14.46M
10-Q · filed 2025-01-15
$33.60M
10-Q · filed 2025-01-15
$57.02M
derived: sum of 3 quarters · filed 2025-07-30
$72.71M
derived: sum of 4 quarters · filed 2025-07-30
2023-08-31$19.14M
10-Q · filed 2024-10-10
$42.56M
derived: sum of 2 quarters · filed 2025-07-30
$58.24M
derived: sum of 3 quarters · filed 2025-07-30
$50.59M
derived: sum of 4 quarters · filed 2025-07-30
2023-05-31$23.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30
$39.11M
derived: sum of 2 quarters · filed 2025-07-30
$31.45M
derived: sum of 3 quarters · filed 2025-07-30
$37.52M
10-K · filed 2025-07-30
2023-02-28$15.68M
10-Q · filed 2024-04-09
$8.03M
derived: sum of 2 quarters · filed 2024-04-09
$14.09M
10-Q · filed 2024-04-09
$32.12M
derived: sum of 4 quarters · filed 2024-07-30
2022-11-30-$7.66M
10-Q · filed 2024-01-09
-$1.59M
10-Q · filed 2024-01-09
$16.43M
derived: sum of 3 quarters · filed 2024-07-30
$22.81M
derived: sum of 4 quarters · filed 2024-07-30
2022-08-31$6.06M
10-Q · filed 2023-10-10
$24.09M
derived: sum of 2 quarters · filed 2024-07-30
$30.47M
derived: sum of 3 quarters · filed 2024-07-30
$42.94M
derived: sum of 4 quarters · filed 2024-07-30
2022-05-31$18.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30
$24.40M
derived: sum of 2 quarters · filed 2024-07-30
$36.87M
derived: sum of 3 quarters · filed 2024-07-30
$58.62M
10-K · filed 2024-07-30
2022-02-28$6.38M
10-Q · filed 2023-04-04
$18.85M
derived: sum of 2 quarters · filed 2023-04-04
$40.59M
10-Q · filed 2023-04-04
$60.85M
derived: sum of 4 quarters · filed 2023-08-15
2021-11-30$12.47M
10-Q · filed 2023-01-09
$34.21M
10-Q · filed 2023-01-09
$54.47M
derived: sum of 3 quarters · filed 2023-08-15
$70.24M
derived: sum of 4 quarters · filed 2023-08-15
2021-08-31$21.75M
10-Q · filed 2022-09-30
$42.00M
derived: sum of 2 quarters · filed 2023-08-15
$57.77M
derived: sum of 3 quarters · filed 2023-08-15
$77.02M
derived: sum of 4 quarters · filed 2023-08-15
2021-05-31$20.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15
$36.03M
derived: sum of 2 quarters · filed 2023-08-15
$55.27M
derived: sum of 3 quarters · filed 2023-08-15
$74.17M
10-K · filed 2023-08-15
2021-02-28$15.77M
10-Q · filed 2022-04-01
$35.02M
derived: sum of 2 quarters · filed 2022-04-01
$53.91M
10-Q · filed 2022-04-01
$73.86M
derived: sum of 4 quarters · filed 2022-07-27
2020-11-30$19.25M
10-Q · filed 2021-12-30
$38.14M
10-Q · filed 2021-12-30
$58.08M
derived: sum of 3 quarters · filed 2022-07-27
$71.13M
derived: sum of 4 quarters · filed 2022-07-27
2020-08-31$18.89M
10-Q · filed 2021-09-30
$38.84M
derived: sum of 2 quarters · filed 2022-07-27
$51.88M
derived: sum of 3 quarters · filed 2022-07-27
$70.15M
derived: sum of 4 quarters · filed 2022-07-27
2020-05-31$19.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27
$32.99M
derived: sum of 2 quarters · filed 2022-07-27
$51.26M
derived: sum of 3 quarters · filed 2022-07-27
$67.52M
10-K · filed 2022-07-27
2020-02-29$13.04M
10-Q · filed 2021-03-31
$31.32M
derived: sum of 2 quarters · filed 2021-03-31
$47.58M
10-Q · filed 2021-03-31
$66.31M
derived: sum of 4 quarters · filed 2021-07-30
2019-11-30$18.27M
10-Q · filed 2020-12-29
$34.54M
10-Q · filed 2020-12-29
$53.27M
derived: sum of 3 quarters · filed 2021-07-30
$67.91M
derived: sum of 4 quarters · filed 2021-07-30
2019-08-31$16.26M
10-Q · filed 2020-09-30
$34.99M
derived: sum of 2 quarters · filed 2021-07-30
$49.63M
derived: sum of 3 quarters · filed 2021-07-30
$67.88M
derived: sum of 4 quarters · filed 2021-07-30
2019-05-31$18.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30
$33.37M
derived: sum of 2 quarters · filed 2021-07-30
$51.62M
derived: sum of 3 quarters · filed 2021-07-30
$68.09M
10-K · filed 2021-07-30
2019-02-28$14.64M
10-Q · filed 2020-04-03
$32.88M
derived: sum of 2 quarters · filed 2020-04-03
$49.36M
10-Q · filed 2020-04-03
$69.22M
derived: sum of 4 quarters · filed 2020-07-30
2018-11-30$18.25M
10-Q · filed 2018-12-28
$34.73M
10-Q · filed 2019-12-27
$54.58M
derived: sum of 3 quarters · filed 2020-07-30
$70.50M
derived: sum of 4 quarters · filed 2020-07-30
2018-08-31$16.48M
10-Q · filed 2019-09-26
$36.34M
derived: sum of 2 quarters · filed 2020-07-30
$52.25M
derived: sum of 3 quarters · filed 2020-07-30
$70.25M
derived: sum of 4 quarters · filed 2020-07-30
2018-05-31$19.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30
$35.77M
derived: sum of 2 quarters · filed 2020-07-30
$53.77M
derived: sum of 3 quarters · filed 2020-07-30
$70.19M
10-K · filed 2020-07-30
2018-02-28$15.91M
10-Q · filed 2019-03-29
$33.91M
derived: sum of 2 quarters · filed 2019-03-29
$50.34M
10-Q · filed 2019-03-29
$69.33M
derived: sum of 4 quarters · filed 2019-07-30
2017-11-30$18.00M
10-Q · filed 2018-12-28
$34.42M
10-Q · filed 2018-12-28
$53.42M
derived: sum of 3 quarters · filed 2019-07-30
$67.77M
derived: sum of 4 quarters · filed 2019-07-30
2017-08-31$16.42M
10-Q · filed 2018-10-05
$35.42M
derived: sum of 2 quarters · filed 2019-07-30
$49.77M
derived: sum of 3 quarters · filed 2019-07-30
$66.63M
derived: sum of 4 quarters · filed 2019-07-30
2017-05-31$19.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30
$33.35M
derived: sum of 2 quarters · filed 2019-07-30
$50.20M
derived: sum of 3 quarters · filed 2019-07-30
$64.94M
10-K · filed 2019-07-30
2017-02-28$14.35M
10-Q · filed 2018-03-29
$31.20M
derived: sum of 2 quarters · filed 2018-03-29
$45.95M
10-Q · filed 2018-03-29
$61.57M
derived: sum of 4 quarters · filed 2018-07-27
2016-11-30$16.85M
10-Q · filed 2018-01-05
$31.59M
10-Q · filed 2018-01-05
$47.22M
derived: sum of 3 quarters · filed 2018-07-27
$58.47M
derived: sum of 4 quarters · filed 2018-07-27
2016-08-31$14.74M
10-Q · filed 2017-09-29
$30.37M
derived: sum of 2 quarters · filed 2018-07-27
$41.62M
derived: sum of 3 quarters · filed 2018-07-27
$56.23M
derived: sum of 4 quarters · filed 2018-07-27
2016-05-31$15.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27
$26.88M
derived: sum of 2 quarters · filed 2018-07-27
$41.49M
derived: sum of 3 quarters · filed 2018-07-27
$56.39M
10-K · filed 2018-07-27
2016-02-29$11.25M
10-Q · filed 2017-03-31
$25.87M
derived: sum of 2 quarters · filed 2017-03-31
$40.76M
10-Q · filed 2017-03-31
$55.38M
derived: sum of 4 quarters · filed 2017-07-28
2015-11-30$14.61M
10-Q · filed 2016-12-29
$29.51M
10-Q · filed 2016-12-29
$44.13M
derived: sum of 3 quarters · filed 2017-07-28
$56.29M
derived: sum of 4 quarters · filed 2017-07-28
2015-08-31$14.89M
10-Q · filed 2016-09-30
$29.52M
derived: sum of 2 quarters · filed 2017-07-28
$41.68M
derived: sum of 3 quarters · filed 2017-07-28
$54.57M
derived: sum of 4 quarters · filed 2017-07-28
2015-05-31$14.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28
$26.78M
derived: sum of 2 quarters · filed 2017-07-28
$39.68M
derived: sum of 3 quarters · filed 2017-07-28
$53.12M
10-K · filed 2017-07-28
2015-02-28$12.16M
10-Q · filed 2016-03-31
$25.06M
derived: sum of 2 quarters · filed 2016-03-31
$38.50M
10-Q · filed 2016-03-31
$49.49M
derived: sum of 4 quarters · filed 2016-07-29
2014-11-30$12.90M
10-Q · filed 2016-01-08
$26.34M
10-Q · filed 2016-01-08
$37.33M
derived: sum of 3 quarters · filed 2016-07-29
$47.62M
derived: sum of 4 quarters · filed 2016-07-29
2014-08-31$13.44M
10-Q · filed 2015-09-30
$24.43M
derived: sum of 2 quarters · filed 2016-07-29
$34.72M
derived: sum of 3 quarters · filed 2016-07-29
$44.41M
derived: sum of 4 quarters · filed 2016-07-29
2014-05-31$10.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29
$21.28M
derived: sum of 2 quarters · filed 2016-07-29
$30.97M
derived: sum of 3 quarters · filed 2016-07-29
$43.39M
10-K · filed 2016-07-29
2014-02-28$10.29M
10-Q · filed 2015-04-01
$19.98M
derived: sum of 2 quarters · filed 2015-04-01
$32.40M
10-Q · filed 2015-04-01
$42.64M
derived: sum of 4 quarters · filed 2015-07-30
2013-11-30$9.69M
10-Q · filed 2014-12-30
$22.11M
10-Q · filed 2014-12-30
$32.34M
derived: sum of 3 quarters · filed 2015-07-30
$42.01M
derived: sum of 4 quarters · filed 2015-07-30
2013-08-31$12.42M
10-Q · filed 2014-09-30
$22.65M
derived: sum of 2 quarters · filed 2015-07-30
$32.32M
derived: sum of 3 quarters · filed 2015-07-30
$42.80M
derived: sum of 4 quarters · filed 2015-07-30
2013-05-31$10.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30
$19.90M
derived: sum of 2 quarters · filed 2015-07-30
$30.38M
derived: sum of 3 quarters · filed 2015-07-30
$40.71M
10-K · filed 2015-07-30
2013-02-28$9.67M
10-Q · filed 2014-04-04
$20.14M
derived: sum of 2 quarters · filed 2014-04-04
$30.47M
10-Q · filed 2014-04-04
$39.17M
derived: sum of 4 quarters · filed 2014-07-30
2012-11-30$10.48M
10-Q · filed 2014-01-09
$20.80M
10-Q · filed 2014-01-09
$29.50M
derived: sum of 3 quarters · filed 2014-07-30
$37.05M
derived: sum of 4 quarters · filed 2014-07-30
2012-08-31$10.33M
10-Q · filed 2013-09-30
$19.02M
derived: sum of 2 quarters · filed 2014-07-30
$26.57M
derived: sum of 3 quarters · filed 2014-07-30
$34.72M
derived: sum of 4 quarters · filed 2014-07-30
2012-05-31$8.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30
$16.25M
derived: sum of 2 quarters · filed 2014-07-30
$24.39M
derived: sum of 3 quarters · filed 2014-07-30
$33.74M
10-K · filed 2014-07-30
2012-02-29$7.55M
10-Q · filed 2013-03-28
$15.69M
derived: sum of 2 quarters · filed 2013-03-28
$25.04M
10-Q · filed 2013-03-28
$33.59M
derived: sum of 4 quarters · filed 2013-07-30
2011-11-30$8.14M
10-Q · filed 2012-12-28
$17.49M
10-Q · filed 2012-12-28
$26.04M
derived: sum of 3 quarters · filed 2013-07-30
$34.10M
derived: sum of 4 quarters · filed 2013-07-30
2011-08-31$9.35M
10-Q · filed 2012-09-28
$17.89M
derived: sum of 2 quarters · filed 2013-07-30
$25.96M
derived: sum of 3 quarters · filed 2013-07-30
$35.59M
derived: sum of 4 quarters · filed 2013-07-30
2011-05-31$8.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30
$16.61M
derived: sum of 2 quarters · filed 2013-07-30
$26.24M
derived: sum of 3 quarters · filed 2013-07-30
$35.84M
10-K · filed 2013-07-30
2011-02-28$8.06M
10-Q · filed 2012-03-30
$17.69M
derived: sum of 2 quarters · filed 2012-03-30
$27.29M
10-Q · filed 2012-03-30
2010-11-30$9.63M
10-Q · filed 2011-12-30
$19.23M
10-Q · filed 2011-12-30
2010-08-31$9.60M
10-Q · filed 2011-09-30
2010-05-31$26.88M
10-K · filed 2012-07-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93